Skip to main content
Eastwood Bio-Medical Canada Inc. logo

Eastwood Bio-Medical Canada Inc. — Investor Relations & Filings

Ticker · EBM TSXV Wholesale and retail trade
Open in API
Filings indexed 104 across all filing types
Latest filing 2026-04-02 Regulatory Filings
Country CA Canada
Listing TSXV EBM

About Eastwood Bio-Medical Canada Inc.

https://eleotin.ca/

Eastwood Bio-Medical Canada Inc. is engaged in the marketing and distribution of natural health products and supplements, primarily serving markets in North America and Asia. The company is a licensed distributor of the Eleotin line of products. It focuses on the development and commercialization of health solutions, including treatments for non-insulin related conditions. As the Canadian subsidiary of Eastwood Companies, its products sold domestically comply strictly with regulatory standards and hold specific Health Canada Product Licenses.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” under NI 52-109, signed by the CEO certifying the interim financial report and MD&A. It is not the interim report itself but a statutory certification form required by securities regulators. There is no specific category for such certificates, so it falls under the fallback “Regulatory Filings” category.
2026-04-02 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a standalone certification form under Canadian NI 52-109 (Form 52-109FV2), signed by the CFO, certifying the interim financial report and MD&A for the period. It is not the full interim report itself (which would be an IR) nor does it present financial results, but is rather a regulatory compliance certificate. Therefore it best fits the general Regulatory Filings (RNS) category as a fallback for such regulatory disclosures.
2026-04-02 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “MANAGEMENT’S DISCUSSION AND ANALYSIS FOR THE PERIOD ENDED JANUARY 31, 2026” and contains narrative commentary by management on the company’s operations, results of operations, business strategy, and risk factors. This corresponds exactly to a Management’s Discussion and Analysis (MDA) filing rather than an announcement or regulatory notice. Therefore, the correct classification is MDA.
2026-04-02 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive set of unaudited condensed interim financial statements for Eastwood Bio-Medical Canada Inc. for the three-month period ended January 31, 2026. It includes a statement of financial position, statement of loss and comprehensive loss, statement of changes in shareholders' equity, statement of cash flows, and detailed notes to the financial statements. This meets the definition of an Interim/Quarterly Report (IR) as it contains substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2026
2026-04-02 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Venture Issuer Basic Certificate” certifying the interim financial report and interim MD&A under NI 52-109. It is not the interim report itself (IR), not an audit report (AR), nor an announcement of publication (RPA). This certificate is a regulatory filing requirement and does not fit any other specific category, so it is classified as a general Regulatory Filing (RNS).
2025-09-30 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is ‘‘Form 52-109FV2 – Certification of Interim Filings’’ under NI 52-109 for a venture issuer’s interim financial report and MD&A. It is not the interim report itself (IR) nor an announcement of its publication (RPA), but a statutory certificate accompanying regulatory filings. It does not fit other specific categories, so it defaults to a general regulatory filing (RNS).
2025-09-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.